Bioavailability of three novel oral, sustained-release pellets, relative to an immediate-release tablet containing 500 mg flucytosine: A randomized, open-label, crossover study in healthy volunteers

Vishal Goyal*, Edrich Krantz, Francois Simon, Anouk Neven, Johanna Eriksson, Amaria Saayman, Nabila Ibnou Zekri Lassout, Mathieu Louis, Stephen Robinson, Abhijit Deshmukh, Amit Antarkar, Carol Ruffell, Sarika Victor, Marylore Chenel, Aljosa Celebic, Henri Caplain, Jean Yves Gillon, Isabela Ribeiro

*Corresponding author for this work

    Research output: Contribution to journalArticleResearchpeer-review

    1 Citation (Scopus)

    Fingerprint

    Dive into the research topics of 'Bioavailability of three novel oral, sustained-release pellets, relative to an immediate-release tablet containing 500 mg flucytosine: A randomized, open-label, crossover study in healthy volunteers'. Together they form a unique fingerprint.

    Pharmacology, Toxicology and Pharmaceutical Science